The nation of Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (£272m) over five years due to Washington's insistence on confidential biological samples.
The decision was revealed after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman later stated that the US was seeking genetic material for research and commercial purposes but was unwilling to guarantee the resulting advantages from any future vaccines.
"We are forced to start the difficult and regrettable process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged more talks to reach a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Implications
This development follows a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were raised about the safety of citizens' health data.
After resuming office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral deals to enhance transparency and accountability.
As per statements, Sixteen nations in Africa have so far signed similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any equivalent assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Put simply, our nation would supply the basic resources for medical research with no assurance that the end products would be accessible to our people if a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending systems previously set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This framework is intended to ensure that when a country provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to further discussions with our US partners on how subsequent collaboration could be arranged in a manner that honours the independence and interests of each country."
Health Experts Reaction
A leading public health body expressed it acknowledged the official position, but suggested that negotiations need to persist given that much of the country's Aids initiatives were funded by external financing.
"In cases where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
This impasse highlights the complex challenges between receiving much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.